Top Markets
Coin of the day
Gentian Diagnostics AS Gentian Diagnostics AS

Gentian Diagnostics AS

GENT
Rang in Aktien #24261
Gentian Diagnostics ASA develops, manufactures, and sells biochemical reagents... Gentian Diagnostics ASA develops, manufactures, and sells biochemical reagents for use in medical diagnostics and research in the United States, Asia, and Europe. It offers in-vitro diagnostic reagents for clinical chemistry analyzers, such as Gentian Calprotectin Immunoassay, a turbidimetric assay used for the measurement of circulating calprotectin in plasma and serum for detection and assessment of inflammation; Gentian Cystatin C Immunoassay test kit, a GFR marker for the diagnosis and therapeutic control of renal function and chronic kidney disease; Gentian Retinol-Binding Protein Immunoassay for detection of retinol-binding protein in human serum and plasma; and Canine CRP Immunoassay test kit, a particle-enhanced turbidimetric immunoassay for quantitative determination of canine C-reactive protein in dog plasma and serum. The company also develops faecal calprotectin immunoassay turbo that offers results of calprotectin concentration in stool supporting diagnosis of inflammatory bowel disease; and faecal pancreatic elastase immunoassay turbo, which allows analysis of pancreatic elastase in stool to aid in diagnosis of pancreatic exocrine insufficiency. Gentian Diagnostics ASA was founded in 2001 and is headquartered in Moss, Norway.
Aktienkurs
$4.07
Zuletzt synchronisiert: 2026-08-21
Marktkapitalisierung
$62.87M
Veränderung (1 Tag)
3.19%
Veränderung (1 Jahr)
-28.25%
Land
NO
Handel Gentian Diagnostics AS (GENT)

Kategorie

Preis GENT mit Marktkapitalisierung von B
Gentian Diagnostics AS Gentian Diagnostics AS
GENT
$4.07
Marktkapitalisierung von Gentian Diagnostics AS(GENT)
Marktkapitalisierung: $62.87M
Mit Stand August 2026 hat Gentian Diagnostics AS eine Marktkapitalisierung von $62.87M. Das macht Gentian Diagnostics AS laut unseren Daten zum 24261st wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Gentian Diagnostics AS von 2016 bis 2026
GENT im Vergleich zu den Top 5 der beliebtesten stocks
Preis für GENT Vermögenswert B Marktkapitalisierung von B Ergebnisse
Gentian Diagnostics AS Gentian Diagnostics AS
$337,119 $62.87M
$5.211T +8,289,352.54%
Gentian Diagnostics AS Gentian Diagnostics AS
$294,125 $62.87M
$4.547T +7,232,171.57%
Gentian Diagnostics AS Gentian Diagnostics AS
$269,267 $62.87M
$4.162T +6,620,933.30%
Gentian Diagnostics AS Gentian Diagnostics AS
$232,414 $62.87M
$3.593T +5,714,764.72%
Gentian Diagnostics AS Gentian Diagnostics AS
$180,667 $62.87M
$2.793T +4,442,347.62%